BRIEF published on 07/22/2024 at 16:43, 4 months ago Dalata Hotel Group PLC: Major Shareholding Notification Voting Rights Regulatory Compliance Major Holdings FMR LLC Dalata Hotel
PRESS RELEASE published on 07/22/2024 at 16:38, 4 months ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* FMR LLC discloses 8% voting rights in Dalata Hotel Group PLC on 18 July 2024. Notification made to issuer and Central Bank of Ireland on 22 July 2024 Voting Rights Notification FMR LLC Dalata Hotel Group Plc Central Bank Of Ireland
BRIEF published on 07/19/2024 at 16:09, 4 months 3 days ago Dalata Hotel Group PLC: Notification of Major Holdings by FMR LLC Voting Rights Regulatory Compliance FMR LLC Shareholdings Dalata
PRESS RELEASE published on 07/19/2024 at 16:04, 4 months 3 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* FMR LLC notifies holding of 7.97% voting rights in Dalata Hotel Group PLC. Threshold crossed on 16 July 2024 Voting Rights FMR LLC Dalata Hotel Group Plc Threshold Holding Notification
BRIEF published on 07/15/2024 at 11:07, 4 months 7 days ago Dalata Hotel Group PLC: Block Listing Review Securities Financial Report Block Listing Dalata Hotel Group Incentive Plan
PRESS RELEASE published on 07/15/2024 at 11:02, 4 months 7 days ago Dalata Hotel Group PLC: Block listing Review Dalata Hotel Group PLC releases a block listing review for its Save as You Earn Scheme and 2017 Long-Term Incentive Plan. Details include unallotted securities and contact information Securities Dalata Hotel Group Plc Block Listing Review Save As You Earn Scheme 2017 Long-Term Incentive Plan
BRIEF published on 07/02/2024 at 13:40, 4 months 20 days ago Dalata Hotel Group PLC Announces Total Voting Rights Share Capital Total Voting Rights Dalata Hotel Group Transparency Directive
PRESS RELEASE published on 07/02/2024 at 13:35, 4 months 20 days ago Dalata Hotel Group PLC: TVR-Total Voting Rights Dalata Hotel Group PLC announces total voting rights of 224,430,160 shares consistent with regulatory requirements. Learn more at www.dalatahotelgroup.com Shareholders Total Voting Rights Dalata Hotel Group Plc Hotel Operator Transparency Regulations
BRIEF published on 06/27/2024 at 08:05, 4 months 26 days ago Dalata Hotel Group PLC: HY 2024 Trading Update Adjusted EBITDA RévPAR Dalata Hotel Group UK Expansion HY 2024
PRESS RELEASE published on 06/27/2024 at 08:00, 4 months 26 days ago Dalata Hotel Group PLC: HY 2024 Trading Update Dalata Hotel Group PLC provides a HY 2024 trading update, with RevPAR outperforming 2023 levels in May and June. Adjusted EBITDA expected to surpass 2023 levels Adjusted EBITDA Trading Update Dalata Hotel Group Plc RévPAR HY 2024
Published on 11/22/2024 at 23:55, 8 hours 57 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 22 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 9 hours 47 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 22 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 37 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 14 hours 58 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 15 hours 56 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 16 hours 51 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 1 hour ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
